Kan D - Search Results

1

Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml.

Meeks JJ, Loeb S, Helfand BT, Kan D, Smith ND, Catalona WJ. Meeks JJ, et al. Among authors: kan d. J Urol. 2009 Jun;181(6):2515-8; discussion 2518-9. doi: 10.1016/j.juro.2009.01.102. Epub 2009 Apr 16. J Urol. 2009. PMID: 19371879 Free PMC article.

2

Prostate specific antigen assay standardization bias could affect clinical decision making.

Loeb S, Chan DW, Sokoll L, Kan D, Maggiore J, Mikolajczyk SD, Mondo DM, Griffin CR, Catalona WJ. Loeb S, et al. Among authors: kan d. J Urol. 2008 Nov;180(5):1959-62; discussion 1962-3. doi: 10.1016/j.juro.2008.07.036. Epub 2008 Sep 17. J Urol. 2008. PMID: 18801532

3

Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease.

Helfand BT, Mongiu AK, Kan D, Kim DY, Loeb S, Roehl KA, Meeks JJ, Smith ND, Catalona WJ. Helfand BT, et al. Among authors: kan d. BJU Int. 2009 Aug;104(3):304-9. doi: 10.1111/j.1464-410X.2009.08421.x. Epub 2009 Feb 23. BJU Int. 2009. PMID: 19239451

4

Pathological outcomes associated with the 17q prostate cancer risk variants.

Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ. Helfand BT, et al. Among authors: kan d. J Urol. 2009 Jun;181(6):2502-7. doi: 10.1016/j.juro.2009.01.109. Epub 2009 Apr 16. J Urol. 2009. PMID: 19371897 Free PMC article.

5

Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures.

Carvalhal GF, Griffin CR, Kan D, Loeb S, Catalona WJ. Carvalhal GF, et al. Among authors: kan d. BJU Int. 2010 Jun;105(12):1650-3. doi: 10.1111/j.1464-410X.2009.09034.x. Epub 2009 Nov 3. BJU Int. 2010. PMID: 19888968 Free PMC article.

6

Is statin use associated with prostate cancer aggressiveness?

Loeb S, Kan D, Helfand BT, Nadler RB, Catalona WJ. Loeb S, et al. Among authors: kan d. BJU Int. 2010 May;105(9):1222-5. doi: 10.1111/j.1464-410X.2009.09007.x. Epub 2009 Nov 3. BJU Int. 2010. PMID: 19888973 Free PMC article.

7

Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?

Loeb S, Roehl KA, Helfand BT, Kan D, Catalona WJ. Loeb S, et al. Among authors: kan d. J Urol. 2010 Jan;183(1):112-6. doi: 10.1016/j.juro.2009.08.156. J Urol. 2010. PMID: 19913814 Free PMC article.

8

Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols.

Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ. Thaxton CS, et al. Among authors: kan d. Urology. 2010 Feb;75(2):414-8. doi: 10.1016/j.urology.2009.07.1353. Epub 2009 Dec 5. Urology. 2010. PMID: 19963249 Free PMC article.

9

[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.

Le BV, Griffin CR, Loeb S, Carvalhal GF, Kan D, Baumann NA, Catalona WJ. Le BV, et al. Among authors: kan d. J Urol. 2010 Apr;183(4):1355-9. doi: 10.1016/j.juro.2009.12.056. Epub 2010 Feb 19. J Urol. 2010. PMID: 20171670 Free PMC article.

10

Preoperative prostate specific antigen doubling time is not a useful predictor of biochemical progression after radical prostatectomy.

Loeb S, Kan D, Yu X, Roehl KA, Catalona WJ. Loeb S, et al. Among authors: kan d. J Urol. 2010 May;183(5):1816-21. doi: 10.1016/j.juro.2010.01.011. Epub 2010 Mar 29. J Urol. 2010. PMID: 20303104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters